Danaher designs, manufactures and markets medical, industrial and commercial products and services. Co.'s segments are: Biotechnology, which includes the bioprocessing and discovery and medical businesses and provides tools, consumables and services; Life Sciences, which provides instruments and consumables to understand the causes of disease, identify new therapies, and test and manufacture new drugs, vaccines and gene editing technologies; Diagnostics, which provides clinical instruments, reagents, consumables, software and services; and Environmental and Applied Solutions, which provides products and services that help protect resources and keep global food and water supplies safe. The DHR stock yearly return is shown above.
The yearly return on the DHR stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the DHR annual return calculation with any dividends reinvested as applicable (on ex-dates).
|